PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE

• DOI: 10.1097/01.ju.0001008596.32809.c5.04
• Publication Date: 2024-04-15T21:33:57Z
• Authors: Daniel D. Shapiro; Jose A. Karam; Viraj A. Master; Philippe E. Spiess; Charles C. Peyton; Sarah P. Psutka; Jay D. Raman; Chiara Mercinelli; Edouard Nicaise; Nicholas D. Rober...; R. Barry Sirard; Amber Jani; Andrea Necchi; Wade J. Sexton; Brandon J. Manley; Dattatraya Patil; Glenn O. Allen; Surena F. Matin; Edwin J. Abel